Carling et al, 1997, Jrnl of Clinical Endocrinology and Metabolism, vol. 82, No. 6 p. 1772.* |
Boucher, “Inadequate Vitamin D Status: Does it Contribute to the Disorders Comprising Syndrome ‘X’,” British Journal of Nutrition, 79:317, 319, 321 (1998). |
Brunvand et al., “Congestive Heart Failure by Vitamin D Deficiency,” Acta Paaediatr, 84:106-108 (1995). |
Carling et al., “Vitamin D Receptor Genotypes in Primary Hyperparathyroidism,” Nature Medicine, 1(12):1309-1310 (1995). |
Haussler et al., “The Vitamin D Hormone and its Nuclear Receptor: Molecular Actions and Disease States,” J. Endocrinology, 54:S57-S73 (1997). |
Holick, M.F., “Noncalcemic Actions of 1, 25-Dihydroxyvitamin D3 Clinical Applications,” Bone (GB, Pergamon Press, Oxford), 17(2):107S-111S (1995). |
Scragg et al., “Myocardial Infarction is Inversely Assocated with Plasma 25-Hydroxyvitamin D3 Levels: A Community-Based Study,” Int. J. Epidemiology, 19(3):559-563 (1990). |
Uitterlinden et al., “A Large Scale Population Based Study of the Association of Vitamin D Receptor Gene Polymorphisms with Bone Mineral Density,” Journal of Bone and Mineral Research, 11(9):1241-1248 (1996). |
Van Schooten et al., “Putative Susceptibility Markers of Coronary Artery Disease: Association Between VDR Genotype, Smoking, and Aromatic DNA Adduct Levels in Human Right Atrial Tissue,” The FASEB Journal, 12:1409-1417 (1998). |
Carling et al., “Vitamin D Receptor Polymorphisms Correlate to Parathyroid Cell Function in Primary Hyperthyroidism,” JCME&E, 82(6):1772-1775 (1997). |
Carling et al., “Vitamin D Receptor (VDR) and Parathyroid Hormone Messenger Ribonucleic Acid Levels Correspond to Polymorphic VDR Alleles in Human Parathyroid Tumors,” JCE&E, 83(7):2255-2259 (1998). |
Vintzileos, A.M. et al., “Fetal Atrial Flutter and X-linked Dominant Vitamin D Resistant Rickets,” Obstet. Gynocol., 65:39S-44S (1985). |
Kessel L., “Sick Sinus Syndrome Cured by Vitamin D?,” Geriatrics, 45:83-85 (1990). |
O'Connell, T.D. et al., “Regulation of Myosin Isozyme Expression by Vitamin D3 deficiency and 1,25-dihydroxyvitamin D3 in the Rat Heart,” Endocrinology, 134:899-905 (1994). |
Weishaar, R.E. et al., “Involvement of Vitamin D3 with Cardiovascular Function III. Effects on Physical Morphological Properties,” Am. J. Physiol., 258(Endocrinol. Metab. 21):E134-E142 (1990). |
Weishaar, R.E. et al., “Involvement of Vitamin D3 with Cardiovascular Function II. Direct and Indirect Effects,” Am. J. Physiol., 253(Endocrinol. Metab. 16):E675-E683 (1987). |
Weishaar, R.E. et al., “Vitamin D3 and Cardiovascular Function in Rats,” J. Clin. Invest., 79:1706-1712 (1987). |